CCCC

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

C4 Therapeutics Inc

NASDAQ | CCCC

2.71

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$259.73M

Market Cap

-

P/E Ratio

-1.67

EPS

$5.10

52 Week High

$1.08

52 Week Low

HEALTHCARE

Sector

CCCC Chart

Recent Chart
Price Action

CCCC Technicals

Tags:

CCCC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $36M
Total Revenue $36M
Cost Of Revenue $7.9M
Costof Goods And Services Sold $7.9M
Operating Income -$120M
Selling General And Administrative $42M
Research And Development $111M
Operating Expenses $155M
Investment Income Net -
Net Interest Income $14M
Interest Income $14M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.8M
Income Before Tax -$105M
Income Tax Expense $131K
Interest And Debt Expense -
Net Income From Continuing Operations -$105M
Comprehensive Income Net Of Tax -
Ebit -$105M
Ebitda -$103M
Net Income -$105M

Revenue & Profitability

Earnings Performance

CCCC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $350M
Total Current Assets $258M
Cash And Cash Equivalents At Carrying Value $55M
Cash And Short Term Investments $55M
Inventory -
Current Net Receivables $3.1M
Total Non Current Assets $92M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $22M
Short Term Investments $189M
Other Current Assets $9.8M
Other Non Current Assets -
Total Liabilities $134M
Total Current Liabilities $45M
Current Accounts Payable $1.3M
Deferred Revenue -
Current Debt -
Short Term Debt $5.8M
Total Non Current Liabilities $88M
Capital Lease Obligations $66M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $66M
Other Current Liabilities $19M
Other Non Current Liabilities -
Total Shareholder Equity $216M
Treasury Stock -
Retained Earnings -$634M
Common Stock $7K
Common Stock Shares Outstanding $69M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$65M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.8M
Capital Expenditures $180K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$51M
Cashflow From Financing $45M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$194K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$105M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $36M
Total Revenue $36M
Cost Of Revenue $7.9M
Costof Goods And Services Sold $7.9M
Operating Income -$120M
Selling General And Administrative $42M
Research And Development $111M
Operating Expenses $155M
Investment Income Net -
Net Interest Income $14M
Interest Income $14M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.8M
Income Before Tax -$105M
Income Tax Expense $131K
Interest And Debt Expense -
Net Income From Continuing Operations -$105M
Comprehensive Income Net Of Tax -
Ebit -$105M
Ebitda -$103M
Net Income -$105M

CCCC News

CCCC Profile

C4 Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

C4 Therapeutics, Inc. is an innovative biopharmaceutical company based in Watertown, Massachusetts, focused on developing advanced therapeutic candidates that selectively target and degrade disease-causing proteins. Specializing in oncology and neurodegenerative diseases, the company's proprietary dynamic protein degradation platform utilizes state-of-the-art biological mechanisms to offer groundbreaking treatment solutions for patients with significant unmet medical needs. Positioned as a leader in the biopharmaceutical industry, C4 Therapeutics is dedicated to transforming patient care by redefining treatment paradigms and improving clinical outcomes through its pioneering approaches.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
TLRY
-19.80%
$0.82
ADAP
-15.14%
$0.05
INTC
+7.72%
$39.65
BYND
-0.98%
$1.01
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+14.79%
$0.28
AGNC
+1.53%
$10.56
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
ONMD
+45.07%
$2.06
SNAP
-0.01%
$7.60
ASST
+0.88%
$1.14
TSLA
+0.55%
$428.96
PCG
+1.78%
$16.01
INHD
-7.36%
$0.20
PLUG
+2.09%
$2.02
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
GPUS
-6.69%
$0.31
NVTS
+3.86%
$8.34
KWM
+12.77%
$0.74
CHR
-4.18%
$0.04
BMNU
+14.89%
$8.64
GRYP
-10.38%
$1.38
CIFR
+8.28%
$20.73
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
TEVA
+5.32%
$26.32
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
DEFT
+10.43%
$1.53
IBRX
+11.50%
$2.37
MARA
+6.70%
$11.85
CAN
+12.59%
$1.03
WULF
+5.18%
$15.61
GOOGL
-0.34%
$318.85
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NIO
+0.64%
$5.49
SMX
+166.32%
$46.34
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
CRCL
+10.93%
$80.58
APLD
+7.21%
$26.74
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
BTG
+2.92%
$4.60
F
+1.06%
$13.33
SOFI
+2.47%
$29.19
KO
+0.37%
$72.88
VALE
+0.63%
$12.59
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
DVLT
-2.58%
$2.07
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
DNN
+1.09%
$2.58
URBN
+13.54%
$77.56
WIT
-0.37%
$2.69
AMD
+0.90%
$216.17
ZIM
+0.97%
$19.70
CRCG
+20.69%
$2.83
AMC
+6.95%
$2.46
PLTR
+0.77%
$167.05
MPW
+2.12%
$5.77
MSTR
+2.37%
$179.82
AMZN
+1.25%
$232.04
IVP
-7.66%
$0.12
TMC
+10.72%
$6.45
SNDK
+3.75%
$223.12
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
TLRY
-19.80%
$0.82
ADAP
-15.14%
$0.05
INTC
+7.72%
$39.65
BYND
-0.98%
$1.01
SOND
-23.45%
$0.12
WBD
+4.00%
$23.88
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
RUBI
-18.08%
$0.17
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+14.79%
$0.28
AGNC
+1.53%
$10.56
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
ONMD
+45.07%
$2.06
SNAP
-0.01%
$7.60
ASST
+0.88%
$1.14
TSLA
+0.55%
$428.96
PCG
+1.78%
$16.01
INHD
-7.36%
$0.20
PLUG
+2.09%
$2.02
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
GPUS
-6.69%
$0.31
NVTS
+3.86%
$8.34
KWM
+12.77%
$0.74
CHR
-4.18%
$0.04
BMNU
+14.89%
$8.64
GRYP
-10.38%
$1.38
CIFR
+8.28%
$20.73
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
TEVA
+5.32%
$26.32
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
DEFT
+10.43%
$1.53
IBRX
+11.50%
$2.37
MARA
+6.70%
$11.85
CAN
+12.59%
$1.03
WULF
+5.18%
$15.61
GOOGL
-0.34%
$318.85
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NIO
+0.64%
$5.49
SMX
+166.32%
$46.34
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
CRCL
+10.93%
$80.58
APLD
+7.21%
$26.74
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
BTG
+2.92%
$4.60
F
+1.06%
$13.33
SOFI
+2.47%
$29.19
KO
+0.37%
$72.88
VALE
+0.63%
$12.59
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
DVLT
-2.58%
$2.07
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
DNN
+1.09%
$2.58
URBN
+13.54%
$77.56
WIT
-0.37%
$2.69
AMD
+0.90%
$216.17
ZIM
+0.97%
$19.70
CRCG
+20.69%
$2.83
AMC
+6.95%
$2.46
PLTR
+0.77%
$167.05
MPW
+2.12%
$5.77
MSTR
+2.37%
$179.82
AMZN
+1.25%
$232.04
IVP
-7.66%
$0.12
TMC
+10.72%
$6.45
SNDK
+3.75%
$223.12
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.